| Jessica A Breton, MOT, OTR/L | |
|
2 Pillsbury St Ste 404, Concord, NH 03301-3549 | |
| (603) 228-7827 | |
| Not Available |
| Full Name | Jessica A Breton |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2 Pillsbury St Ste 404, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689248940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica A Breton, MOT, OTR/L 101 Talent Rd, Litchfield, NH 03052-2452 Ph: (603) 689-4803 | Jessica A Breton, MOT, OTR/L 2 Pillsbury St Ste 404, Concord, NH 03301-3549 Ph: (603) 228-7827 |
News Archive
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.
Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ.
A preliminary report suggests that maternal smoking during pregnancy is associated with increased chromosomal abnormalities in fetal cells, according to a study in the current issue of JAMA.
A new study shows that women who take sugared beverages every day may be raising their risk for heart disease, even if their habit is not packing on the pounds. The researchers say the drinks could be anything - sweet tea, soda, or coffee drinks that look like desserts.
AmpliMed Corporation, a cancer therapeutics company, today announced results from AMP-019, a randomized double-blind, placebo-controlled Phase II screening trial designed to determine if a Phase III trial was warranted for the combination of gemcitabine (Gemzar, Eli Lilly) plus Amplimexon (AmpliMed Corporation) in patients with advanced pancreatic ductal adenocarcinoma of the pancreas.
› Verified 5 days ago
Ms. Barbara Ann Macrae, O.T.R.L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 36 Clinton St, Concord, NH 03301 Phone: 603-271-5699 | |
Corey Siegfried, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Concord, NH 03301 Phone: 603-225-6644 | |
Norma Weller Robinson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Hall St, Suite H, Concord, NH 03301 Phone: 603-228-9160 | |
Martha Capuco, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 124 Hall St, Suite H, Concord, NH 03301 Phone: 603-228-9160 Fax: 603-224-2776 | |
Audrey Knapp, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 Sewalls Falls Rd, Concord, NH 03301 Phone: 603-225-0853 | |
Alison Thompson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 239 Pleasant St, Concord, NH 03301 Phone: 603-410-3418 | |
Mrs. Allison Ann Shippos, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Concord, NH 03301 Phone: 603-225-6644 |